Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Dec 6 2025
Mar 18 2025
Apr 28 2025
Mar 26 2026
Oct 10 2025